Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Perinatal/Neonatal Case Presentation
  • Published:

Perinatal/Neonatal Case Presentation

Transient Neonatal Jitteriness due to Maternal Use of Sertraline (Zoloft®)

Abstract

We describe the occurrence of marked jitteriness and an enhanced startle response in a term infant after being exposed to sertraline in utero. An umbilical cord blood sample taken at the time of birth showed a sertraline concentration (<10 ng/mL) below the reference range. On the third day during the peak of the symptoms, sertraline plasma concentration was <10 ng/mL, while his serotonin level (6 ng/mL) was below the reference range. The neurologic symptoms resolved by the fifth day. To date, there are no reports of transient neonatal jitteriness with maternal use of sertraline documented with low cord and neonatal plasma samples consistent with withdrawal syndrome.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Koren G . SSRIs in pregnancy — are they safe? Pediatr Res 2002;51:424–425.

    Article  PubMed  Google Scholar 

  2. Kulin NA, Pastuszak A, Koren G . Are the new SSRIs safe for pregnant women? Can Fam Physician 1998;44:2081, 2083.

    CAS  PubMed  PubMed Central  Google Scholar 

  3. Nordeng H, Lindemann R, Perminov KV, Reikvam A . Neonatal withdrawal syndrome after in utero exposure to selective serotonin reuptake inhibitors. Acta Paediatr 2001;90:288–291.

    Article  CAS  PubMed  Google Scholar 

  4. Lipsitz PJ . A proposed narcotic withdrawal score for use with newborn infants: A pragmatic evaluation of its efficacy. Clin Pediatr 1975;14:592–594.

    Article  CAS  Google Scholar 

  5. Associate Regional and University Pathologist. The hospital's designated core laboratory website: http://www.aruplab.com.

  6. Doogan DP, Caillard V . Sertraline: A new antidepressant. J Clin Psychiatry 1988;49(Suppl):46–51.

    PubMed  Google Scholar 

  7. Volpe JJ . Neurology of the newborn. Philadelphia, PA: WB Saunders Co; 1995, p. 118, 181–182.

  8. Miller RD . Anesthesia. Philadelphia, PA: Churchill Livingstone; 2000 p 2047–2050.

  9. Micromedex (R) Healthcare Series. Cefotetan — Adverse Reactions, Central Nervous System, Kernicterus: Thomson Micromedex Series, Vol. 119; 2004 (Online quick links — State University of New York, Upstate Medical University, Health Science Library: http://www.upstate.edu/library/).

  10. Louie AK, Lannon RA, Ajari LJ . Withdrawal reaction after sertraline discontinuation. Am J Psychiatry 1994;151:450–451.

    CAS  PubMed  Google Scholar 

  11. Kent LSW, Laidlaw JDD . Suspected congenital sertraline dependence. Br J Psychiatry 1995;167:412–413.

    Article  CAS  PubMed  Google Scholar 

  12. Oca MJ, Donn SM . Association of maternal sertraline (Zoloft) therapy and transient neonatal nystagmus. J Perinatol 1999;19:460–461.

    Article  CAS  PubMed  Google Scholar 

  13. Hendrick V, Stowe ZN, Altschuler LL, Hwang S, Lee E, Haynes D . Placental passage of antidepressant medications. Am J Psychiatry 2003;160:993–996.

    Article  PubMed  Google Scholar 

  14. Benmansour S, Owens WA, Cecchi M, Morilak DA, Frazer A . Serotonin clearance in vivo is altered to a greater extent by antidepressant-induced downregulation of the serotonin transporter than by acute blockade of this transporter. J Neurosci 2002;22:6766–6772.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Committee on Drugs — American Academy of Pediatrics. Use of psychoactive medication during pregnancy and possible effects on the fetus and newborn. Pediatrics 2000;105:880–887.

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Santos, R., Pergolizzi, J. Transient Neonatal Jitteriness due to Maternal Use of Sertraline (Zoloft®). J Perinatol 24, 392–394 (2004). https://doi.org/10.1038/sj.jp.7211115

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.jp.7211115

This article is cited by

Search

Quick links